Ingevity+
Payments companies reported to CMS as associated with Ingevity+. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ingevity+, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ingevity+
These are the largest totals companies reported as associated with Ingevity+. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kevin Trulock | Indianapolis, IN | Clinical Cardiac Electrophysiology | $19,178.66 |
| Daniel Friedman | Durham, NC | Clinical Cardiac Electrophysiology | $18,134.05 |
| Antonio Moretta | Sarasota, FL | Clinical Cardiac Electrophysiology | $16,373.94 |
| Apoor Patel | Sugar Land, TX | Clinical Cardiac Electrophysiology | $15,607.39 |
| Christopher Latanich | Duluth, MN | Cardiovascular Disease | $13,267.74 |
| Paari Dominic | Iowa City, IA | Clinical Cardiac Electrophysiology | $9,849.36 |
| Anil Purohit | West Columbia, SC | Advanced Heart Failure and Transplant Cardiology | $7,750.00 |
| Eric Braunstein | Los Angeles, CA | Clinical Cardiac Electrophysiology | $3,875.00 |
| Jan Lopes | Greenville, NC | Cardiovascular Disease | $2,459.89 |
| Michael Jiang | Los Angeles, CA | Internal Medicine | $2,412.25 |
Prescribed Ingevity+?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.